MAWD Pathology Group is the leading provider of pathology and laboratory professional services in the Kansas City region, with a history spanning over 50 years. With a team of 55 pathologists, MAWD Pathology Group serves over 250,000 patients annually, offering unmatched and diverse advanced subspecialty expertise. The company's commitment to excellence is evident through their board-certified pathologists, specializing in various areas including blood banking and transfusion medicine, cytopathology, molecular genetic pathology, and more. Led by Dr. Samuel Caughron, the company's President and CEO, MAWD Pathology Group prides itself on being privately owned and managed, maintaining strong ties to the community by providing services to numerous hospitals, surgery and endoscopy centers, and physician offices across the region.
General Information
Get notified when MAWD Pathology Group moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track MAWD Pathology Group
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Health Care
About MAWD Pathology Group
Taxonomy: pathology, diagnostics, personalized medicine, laboratory services, subspecialty expertise, anatomic pathology, clinical pathology, cytopathology, dermatopathology, gynecologic pathology, hematopathology, molecular genetic pathology, neuropathology, healthcare services, consultation services
No funding data available for MAWD Pathology Group yet.
Get notified when MAWD Pathology Group raises fundingMAWD Pathology Group Alternatives & Competitors
Excellence in patient care - every diagnosis, every day.
Physicians Reference Laboratory is an integrated, full service laboratory specializing in anatomic,...
A Spirit of Excellence
FAQ About MAWD Pathology Group
Don't just browse. Track.
Signal Tracker monitors MAWD Pathology Group and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.